Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts -: Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation

被引:121
作者
Galbiati, F
Volonté, D
Engelman, JA
Scherer, PE
Lisanti, MP
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA
关键词
D O I
10.1074/jbc.274.42.30315
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Caveolin-8 is the principal structural protein of caveolae membrane domains in striated muscle cells. Caveolin-3 mRNA and protein expression are dramatically induced during the differentiation of C2C12 skeletal myoblasts, coincident with myoblast fusion. In these myotubes, caveolin-3 localizes to the sarcolemma (muscle cell plasma membrane), where it associates with the dystrophin-glycoprotein complex. However, it remains unknown what role caveolin-3 plays in myoblast differentiation and myotube formation. Here, we employ an antisense approach to derive stable C2C12 myoblasts that fail to express the caveolin-3 protein. We show that C2C12 cells harboring caveolin-3 antisense undergo differentiation and express normal amounts of four muscle-specific marker proteins. However, C2C12 cells harboring caveolin-3 antisense fail to undergo myoblast fusion and, therefore, do not form myotubes, Interestingly, treatment with specific p38 mitogen-activated protein kinase inhibitors blocks both myotube formation and caveolin-3 expression, but does not affect the expression of other muscle-specific proteins. In addition, we find that three human rhabdomyosarcoma cell lines do not express caveolin-3 and fail to undergo myoblast fusion, Taken together, these results support the idea that caveolin-3 expression is required fear myoblast fusion and myotube formation, and suggest that p38 is an upstream regulator of caveolin-3 expression.
引用
收藏
页码:30315 / 30321
页数:7
相关论文
共 34 条
[1]   CYTOPLASMIC ACTIVATION OF HUMAN NUCLEAR GENES IN STABLE HETEROCARYONS [J].
BLAU, HM ;
CHIU, CP ;
WEBSTER, C .
CELL, 1983, 32 (04) :1171-1180
[2]  
BONILLA E, 1981, AM J PATHOL, V104, P167
[3]  
COLE F, 1993, J BIOL CHEM, V268, P1580
[4]   Molecular and cellular biology of caveolae - Paradoxes and plasticities [J].
Couet, J ;
Li, SW ;
Okamoto, T ;
Scherer, PE ;
Lisanti, MP .
TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (04) :103-110
[5]   Caveolin-3 is not an integral component of the dystrophin glycoprotein complex [J].
Crosbie, RH ;
Yamada, H ;
Venzke, DP ;
Lisanti, MP ;
Campbell, KP .
FEBS LETTERS, 1998, 427 (02) :279-282
[6]   Stress-activated protein kinase-2 p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis [J].
Cuenda, A ;
Cohen, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) :4341-4346
[7]   Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis [J].
Engelman, JA ;
Lisanti, MP ;
Scherer, PE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32111-32120
[8]   Molecular genetics of the caveolin gene family:: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy [J].
Engelman, JA ;
Zhang, XL ;
Galbiati, F ;
Volonté, D ;
Sotgia, F ;
Pestell, RG ;
Minetti, C ;
Scherer, PE ;
Okamoto, T ;
Lisanti, MP .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (06) :1578-1587
[9]   Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo -: Implications for human breast cancer [J].
Engelman, JA ;
Lee, RJ ;
Karnezis, A ;
Bearss, DJ ;
Webster, M ;
Siegel, P ;
Muller, WJ ;
Windle, JJ ;
Pestell, RG ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) :20448-20455
[10]   Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth [J].
Engelman, JA ;
Wykoff, CC ;
Yasuhara, S ;
Song, KS ;
Okamoto, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16374-16381